Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What BIG Pharma deal news are you meaning? The ones they say in weeks? What is out right now is the one multi-million provider news which they said would be out in few days. And it is right as it is within 2 weeks. So I guess the bigger ones in weeks should be within two months and in that 90 days period after 8th September.
What happens is all the news are out and PPS is stable at low! What is the hope for 2011 holders?! Even 0.03 could be some sort of bottom. So you will wait unitll the election time? Remember this is the firm killing cancers!
current shareholders would receive essentially the same dividend
...meaning that the new Class A shares would receive a greater amount of any total declared dividend as compared to the Class B shares and any current shareholders would receive essentially the same dividend before and after the recapitalization, but that any new issuances of Class A common stock would have increased dividend participation as compared to current shareholders.
Does mean current holders will get something but smaller that the old ones?
Major Initiative to Spur Biofuels Industry Announced
resident Obama has announced that the U.S. Departments of Agriculture, Energy, and Navy will invest up to $510 million during the next three years in partnership with the private sector to produce advanced drop-in aviation and marine biofuels to power military and commercial transportation. The initiative responds to a directive from the President issued in March as part of his Blueprint for a Secure Energy Future, the administration’s framework for reducing dependence on foreign oil. The biofuels initiative is being steered by the White House Biofuels Interagency Work Group and Rural Council, both of which are enabling greater cross-agency collaboration to strengthen rural America.
“Biofuels are an important part of reducing America’s dependence on foreign oil and creating jobs here at home,” said President Obama. “But supporting biofuels cannot be the role of government alone. That’s why we’re partnering with the private sector to speed development of next-generation biofuels that will help us continue to take steps towards energy independence and strengthen communities across our country.”
Increased use of advanced biofuels is a key component of the administration’s energy security agenda, but there is currently a lack of this manufacturing capability for next-generation drop-in biofuels in the United States. To accelerate the production of bio-based jet and diesel fuel for military and commercial purposes, Secretary of Agriculture Tom Vilsack, Secretary of Energy Steven Chu, and Secretary of the Navy Ray Mabus have developed a plan to jointly construct or retrofit several drop-in biofuel plants and refineries. This effort is intended to help address energy security and national security challenges and provide economic opportunities in rural America.
“America’s long-term national security depends upon a commercially viable domestic biofuels market that will benefit taxpayers while simultaneously giving sailors and marines tactical and strategic advantages,” said Navy Secretary Ray Mabus. “Today’s announcement not only leverages our home grown fuel sources to support our national security, but it also helps advance the biofuels market, which ultimately brings down the cost of biofuels for everyone.”
“By building a national biofuels industry, we are creating construction jobs, refinery jobs, and economic opportunity in rural communities throughout the country,” said Agriculture Secretary Vilsack. “As importantly, every gallon of biofuel consumed near where it is produced cuts transportation costs and, for the military, improves energy security.”
“These pioneer plants will demonstrate advanced technologies to produce infrastructure-compatible, drop-in renewable fuels from America’s abundant biomass resources,” said Energy Secretary Chu. “It will support development of a new, rural-focused industry that will replace imported crude oil with secure, renewable fuels made here in the U.S.”
The joint plan calls for the three Departments to invest a total of up to $510 million, which will require substantial cost share from private industry—of at least a one to one match. The partnership aims to reduce U.S. reliance on foreign oil and create jobs while positioning American companies and farmers to be global leaders in advanced biofuels production.
$0.10 per common share!
On June 8, 2011, the Company signed a Consulting Agreement with a Consultant. Under the Agreement, the Company shall issue 1,500,000 144-restricted common shares to the Consultant upon successfully raising $1,000,000 at $0.10 per common share for the Company.
That means 10 million shares sell at 0.10 PPS!
There is no volume till now! This is quite seldom in VRAL. Could it means a turning point is coming?
You changed your idea is based on the NT 10-Q and 10K?
Do you plan to cut the loss now? It could be a good time before too late. Your recent buys on MCET also does not work. Do you find a way to get them back?
You mean these FEW DAYS would not come? The news with multi-million company?
What is inside? saying another delay?
Few days already means 3 weeks. let us see it could also mean months or even forever. Any hopes in this week?
Today is Thursday. If it is not coming today. Then the best is next week. After a few days, everything is forgotten.
Some buying just now?
Not so sure.
Hi I follow you a lot since I saw SFNL. Hope you are right this time! In fact I have much more confidence on RFNN. It will grow for sure. The other one maybe a joke and its time is far away. But if there is a flip would be wonderful.
I just want to hear more voices. It has been too long-term silent here. If you are a long that is fine and I also want to add more at a good price. That means 0.015, right? Not far away.
Viral Genetics Is Moving In The Right Direction
Grant Zeng, CFA
Viral Generics Reports On Progress
On August 3, 2011, Viral Genetics (VRAL) held a its first corporate presentation via webcast. During the webcast, the Company’s CEO Mr. Haig Keledjian reviewed recent and ongoing developments at Viral Genetics and VG Energy. This webcast is also one of the moves the Company is taking to enhance shareholder communications.
According to Mr. Haig, Viral Genetics has made fundamental advancements implementing the Company’s strategic plan in the past six months. Our key takeaways from the webcast include:
HIV/AIDS Program: In early 2011, the Company received feedback from the US FDA on its pre-IND for its HIV/AIDS drug program, APi1177 (VGV-X), asking for more in vitro and animal safety and toxicity studies. Currently, the Company is updating the final protocol and will submit it to FDA within 30 to 60 days. Furthermore, the Company is now completing the securing of a long-term manufacturing relationship for its clinical-grade drug (GLP and GMP). If the IND were approved, the clinical trial would be a Phase I study and require 9-12 months to conduct including preparation, recruitment of study centers, contracting service providers, enrollment of patients, treatment, follow up, and statistical evaluation.
Lyme Disease Program: The Company is in the process of completing its pre-IND for the Lyme Disease drug program. A clinical investigator is now being recruited who will assist in completing the clinical design aspects of the pre-IND.
Drug-Resistant Cancer Program: The investigator study of the Company’s Metabolic Disruption (MDT) compounds for treatment of drug-resistant cancers at Scott and White Hospital is undergoing Institutional Review Board review. The Company expects that this study will commence soon, with approximately 12 months of follow up. The study was funded by an anonymous grant of $1.5 million to Scott and White, specifically directed to the study.
VG Energy – Industrial Scale Testing: Viral Genetics’ majority-owned subsidiary, VG Energy, successfully completed the first phase of an independent industrial-scale demonstration of MDT lipid-enhancing compounds, which resulted in significantly increased yields of oils from algae. The second phase of this testing is dose response analysis, which examines whether manipulation of different quantities of MDT compounds can further enhance yields. Once this portion of testing is complete, it will be followed by industrial scale testing in a closed bioreactor algae-cultivation environment. Final results of this testing are expected within 2-3 months.
VG Energy – Other Testing: VG Energy is also completing testing of MDT compounds on various additional strains of algae and different processes. These tests include algae used in open pond or raceways (a circular configuration for moving nutrients and water through the algal growth pools); “reversing” the lipid-enhancing properties of MDT to increase glucose rather than oils, which reduces the steps needed to convert the algal product to a usable fuel; and testing MDT compounds on yeast used for production of omega-3 fatty acids.
VG Energy – Partnering Efforts: VG Energy is actively engaged in exploring strategic partnerships and business relationships including, but not limited to, licensing or collaborative research relationships with leading firms and academic institutions for the purpose of achieving commercialization and/or developing new applications of MDT compounds in energy, food, cosmetics and nutriceuticals.
Viral Generics Reports First Quarter of 2011 Results
On June 9, 2011, Viral Genetics (VG) filed its quarterly report for the first fiscal quarter ending March 31, 2011.
The Company had no revenue for the first quarter ended March 31, 2011 as expected.
R&D expenses were $0.27 million, SG&A expenses were $0.25 million. Legal and consulting fee were $0.56 million.
Net loss was $1.6 million for the first quarter ended March 31, 2011, or -$0.00 per share.
VG had only $40,191 in cash. While there were $1.9 million long term debts sitting on the balance sheet.
The Implications
We think VG is moving in the right direction.
Although the HIV/AIDS clinical program is a little delayed as originally planned, the commencement of the Phase I clinical study is likely to happen in 4Q11 or 1Q12 when the Company continues to make progress in in vitro and additional animal studies.
Other drug programs such as Lyme disease and Cancer programs are also advance as planned.
At the front of biofuel business, the Company is also making progress in its industrial scale testing. The Company has successfully completed the first phase of an independent industrial-scale demonstration of MDT lipid-enhancing compounds. The second phase of this testing of dose response analysis is ongoing, which will be followed by industrial scale testing in a closed bioreactor algae-cultivation environment.
We believe financial performance is a non-event for VG. Investors will be focused on its balance sheet and its R&D programs advancement. Cash burn is still our chief concern.
VG had only $40,191 in cash. While there were $1.9 million long term debts sitting on the balance sheet. When the Company moves its clinical programs into clinic later this year, R&D expenses will soar. We believe Viral Genetics needs to tap the capital market very soon and will continue to do so on a regular basis before the Company achieves revenue from product sales or establish any partnership with major pharma or biotech companies.
We maintain our Neutral rating on Viral Genetics.
For a free copy of the full research report, please email scr@zacks.com with VRAL as the subject.
Follow Zacks Small Cap Research on Twitter at Twitter.com/ZacksSmallCap
Viral Genetics provides update on VG Energy
By Erin Voegele | August 08, 2011
[<br><small></small>]
Viral Genetics Inc. hosted recently hosted a conference call to update investors and other interested parties on the progress the company has made. This included information on its VG Energy subsidiary, which is working in the algae biofuels sector.
In a statement released prior to the call Viral Genetics CEO Haig Kaledjian said that VG Energy continues to exceed the company’s expectations. “The algal biofuel segment of the alternative energy markets is garnering the largest share of institutional, [venture capital] and corporate investment dollars in the biofuel market, and is seen as the economically viable alternative to petroleum based fuels,” he said. “We are pursuing several pathways for commercialization of VG Energy’s technology.”
According to information released by the company VG Energy has successfully completed the first phase of an independent industrial-scale demonstration of Metabolic Disruption Technology (MDT) lipid-enhancing compounds. The company states that this resulted in significantly increased yields of oils from algae. A statement provided by the company further notes that the second phase of the testing is dose response analysis, which examines whether manipulation of different quantities of MDT compounds can further enhance yields. Once this testing is complete, Viral Genetics said it will be followed by industrial scale testing in a closed bioreactor. Finals results of the testing are expected to be available in two to three months.
In addition VG Energy is also testing MDT compounds on additional strains of algae, and algae grown using different processes. This includes testing in open ponds. The company also states it is actively exploring strategic partnerships and business relationships, including licensing or collaborative research relationships.
“We have only scratched the surface of the market that can benefit from our technology,” said Kaledjian during the call. “The next milestone to watch for the announcement of the conclusion of the proof that we’ve allowed of proof of efficacy in increasing yield and also determined programmed doses in each of these different production facilities.”
If the news we are waiting for comes this week, what will be the response of PPS? I hope it goes to 0.12, but I feel it might be difficult. What are your ideas?
Right, next few days may mean weeks for CBIS, you know that.
Check several posts here or look the Pr CAREFULLY, then you will find out. It is easy to have such an idea, but if you read words by words, you will see those could be different projects.
Hi, just to remind you if you check their Pr carefully, the Pr within this week was already released on Monday. The other one people are waiting will be IN FEW DAYS, which means weeks. So I will not be surprised to see no news until next week. However PPS will go down without news.
Hi, in fact I followed you to the other one. And it is clear it is much better to stay here! I want to have more before too many people come in.
20K shares are surely not enough. You came at a very good time. I bought in more than one year ago and others maybe 4-5 years? And it was a long quiet time with 0 volume and low PPS. But it is coming to the rapid growth phase. I guess 2-3 years to dollar land. There are some chances to buy low. But if wait too long it may leave the station. So do more DD and wish you a good luck! My core position will be kept to dollar and maybe even more!
So this is what we are waiting for in this week? Is UF4A the multi-million dollar pharmaceutical technology provider? No! But CBIS mentioned there will be a Pr about the later one this week! If not, we have to wait more weeks!
What is your target? 0.20 or finally 1 dollar?
If in weeks, when they have got the good deal, they will have the funds to do the def 14C. It is related and it takes WEEKS!
Hi , if it is going good, what would be your idea of the developement of PPS? I guess next step is 0.10-0.20 cents, and in half year it may reach 0.20 cents. But it will need 2-3 years at least to dollar land?
Buying! Buying! What is happenning?! This is quite different in this stock for a long time! What is the rumor? Or it is going to the correct PPS.
Haha, I saw your post there! Sure I am with you also there. But your target might be difficult for the moment. Let us dream!
But in fact, RFNN should go much better than that one. Now suddenly some buying, what is happening ?!
What does DEF 14C mean to us and to CBIS?
This is the link:
http://ih.advfn.com/p.php?pid=nmona&article=48568371
I do not know how this Dividend is going. Why could it be good? What is the difficulty? Why everyone is waiting for this?
(revised) (PRER14C)
All these A, B shares etc. are very complicated. Could someone put it in a simple way how this thing is going? Once it works, why should there a jump of PPS?
RFNN, maybe another good pick! Have a look!
NEPH, it looks very nice! Currently it is below 1 and would come to 5-10 easily.
Who are the 5 posters here? I also want this 100k shares. By the way, it seems no 100k shares available at 0.06 any more.
Thanks for your long letter. From the PR, it is on the right way. But from the market, there was a deep down recently. There seems some planned action behind it. If the VG algae testing went on well, then it means MMs wanted to get more cheaper shares. Hope that is true!
The Dosage Response Study, expected to be completed within a month, ...
The next update on this project will be upon completion of the Industrial Scale Demonstration.
So the best hope is that they found a good dosage now. But no idea about the Industrial Scale Demonstration. Maybe months or years?
Hi, have you got any answers from the company? If they are losing money all the time, how could they be able to buy back the stocks? Or the only hope is the recent big scale testing? When should the results be out? There will be a live meeting on 3rd August. They seem to be confident. Why?
CC is doing well! Growing fast quater by quater. I can wait another two years to see the 0.20 PPS.